查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1869748

生物指示器市场规模、份额和趋势分析报告：按产品、方法、最终用途、地区和细分市场预测（2025-2033 年）

Biological Indicators Market Share, Share & Trends Analysis Report By Product (Self-Contained, Strips, Cards / Rapid Readout BIs), By Method (Steam Sterilization, Ethylene Oxide Sterilization), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

生物指示器市场摘要

2024年全球生物指示器市场规模估计为5.348亿美元，预计2033年将达到11.1亿美元。

预计从 2025 年到 2033 年，该市场将以 8.59% 的复合年增长率成长。这一市场成长是由医疗保健、製药和食品产业对消毒和感染控制日益重视所推动的。

医院感染（HAI）日益受到关注，以及对灭菌流程检验的严格监管要求，推动了对可靠、快速的生物指示器解决方案的需求。此外，快速读数和自动化技术的进步，以及新兴市场对灭菌方法的日益普及，也进一步促进了市场成长。

严格的监管要求在推动生物指示器产业发展方面发挥关键作用。世界各地的卫生监管机构都要求医疗设备、製药和生物技术等产业的灭菌流程检验。生物指示器是验证灭菌效果的黄金标准，也是达到合规性的关键。例如，美国食品药物管理局(FDA) 要求医疗设备製造商根据《联邦法规》第 21 篇第 820 部分（品质系统法规）证明其灭菌检验符合要求。同时，欧洲药品管理局 (EMA) 和 ISO 11138 标准也为生物指示器在无菌保证中的应用制定了具体标准。同样，基于生物指示器的灭菌药品和器械检验对于製药企业遵守良好生产规范 (GMP) 至关重要。这些严格的法规结构确保了患者安全和产品可靠性，从而在关键的医疗保健和生命科学领域创造了对生物指示器的稳定需求。

随着医疗机构日益重视加强感染控制和消毒措施，医院感染（HAI）的不断上升趋势成为推动生物指示器产业发展的主要因素。世界卫生组织发布的《2024年全球感染预防与控制报告》对约400项研究进行了大规模系统性回顾，估计到2023年，全球医院感染的盛行率将达到约14%。此外，2022/2023年在28个欧盟/欧洲经济区成员国和三个西巴尔干国家/地区开展的一项欧洲定点盛行率调查显示，至少发生过一次医院感染的患者已调整的盛行率为8%。医院感染发生率的上升凸显了可靠消毒检验的重要性，并推动了对生物指示剂的需求，以确保在预测期内消毒流程的有效性。

全球外科手术数量的不断增长，从择期手术到复杂的器官移植，推动了对生物指示器产业的需求。医院和手术中心手术量的增加，导致需要检验的灭菌流程的可重复使用器械的常规使用量激增。这种激增造成了吞吐量压力，提高了品质和合规标准，并促使医疗机构实施严格的灭菌检验方法。根据2024年手术统计数据，2024年预计将进行约1,585,878例美容手术，比2023年增加1%。同时，同期重组手术量将增加2%。手术介入的持续成长凸显了生物指标在确保灭菌流程有效性和保障病人安全的重要性。

技术创新正显着改变市场格局，显着提升了灭菌检验的效率、准确性和合规性。例如，快速检测指示剂等创新技术已将确认灭菌效果所需的时间从数天缩短至数小时，从而加快了繁忙医疗机构的设备週转速度。以Solventum公司为例，该公司于2025年6月推出了Attest超快速气化过氧化氢（VH2O2）透明挑战包，这是一款即用型解决方案，将两种先前已获FDA已通过核准的指示剂整合到一个测试系统中。此挑战包将用于检验微生物灭活的生物指示剂（BI）和用于验证灭菌器性能的化学指示剂（CI）组合在一个透明的一次性容器中，从而简化并可靠地验证了灭菌效果。

「透过创新，可以更轻鬆、更可靠、更快速地对所有灭菌模式下的每个灭菌批次进行监控，这将使医疗机构能够持续保持最高的患者安全标准，同时满足现代无菌处理部门不断提高的生产力需求，」医疗保健无菌处理协会 (HSPA) 前任主席 Sharon Green-Golden 表示。

「在生死攸关的消毒环境中，速度和准确性都至关重要，」公司感染预防和外科解决方案业务部高级副总裁道格·巴特利特表示，「Solventum 的创新技术为专业人员提供直观、前沿的资源，帮助他们保护患者健康。这体现了我们致力于在关键环境中持续支持高标准护理的承诺。」

目录

第一章调查方法和范围

第二章执行摘要

第三章 生物指示器市场变数、趋势与范围

  • 市场体系展望
    • 附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 生物指示器市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析

第四章 生物指示器市场：产品估算与趋势分析

  • 细分仪表板
  • 生物指示器市场：产品差异分析及市场占有率（2024 年及 2033 年）
  • 自足式的
  • 条
  • 卡/高速读取 BI
  • 其他的

第五章 生物指示器市场：方法论估算与趋势分析

  • 细分仪表板
  • 生物指示器市场：方法学差异分析及市场占有率（2024 年及 2033 年）
  • 蒸气灭菌
  • 环氧乙烷灭菌
  • 过氧化氢灭菌
  • 放射线杀菌
  • 干热灭菌

第六章：生物指示器市场：终端用途估算与趋势分析

  • 细分仪表板
  • 生物指示器市场：最终用途变化分析及市场份额（2024 年和 2033 年）
  • 医院和诊所
  • 门诊手术中心（ASC）和牙科诊所
  • 生物製药和生物技术公司
  • 医疗设备製造商
  • 合约灭菌服务供应商
  • 研究和学术机构
  • 其他用途

第七章 生物指示器市场：按产品、方法和最终用途分類的区域估算和趋势分析

  • 区域展望
  • 生物指示器市场：区域差异分析及市场占有率（2024 年及 2033 年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 市场参与企业分类
  • 主要企业简介
    • STERIS plc.
    • Solventum
    • Getinge
    • Mesa Laboratories, Inc.
    • 3M
    • Terragene SA
    • Propper Manufacturing Co., Inc.
    • Tuttnauer
    • Ecolab Inc.
    • HWAndersen Products Ltd.
    • MATACHANA GROUP
    • LISTER BIOMEDICAL CO.,LTD
    • Liofilchem Srl
    • Steelco SpA
    • Zhejiang Tailin Bioengineering Co., Ltd.
    • Cole-Parmer Instrument Company, LLC（Antylia Scientific）
    • Anhui Tianrun Medical Packaging Materials Co., Ltd.
    • Medline Industries, LP.
    • True Indicating
  • 公司市占率分析，2024 年
Product Code: GVR-4-68040-757-3

Biological Indicators Market Summary

The global biological indicators market size was estimated at USD 534.80 million in 2024 and is projected to reach USD 1.11 billion by 2033, growing at a CAGR of 8.59% from 2025 to 2033. The growth of the market is attributed due to the growing emphasis on sterilization and infection control across healthcare, pharmaceutical, and food industries.

Increasing concerns over hospital-acquired infections (HAIs) and stringent regulatory requirements for validating sterilization processes are boosting demand for reliable and rapid BI solutions. In addition, advancements in rapid-readout and automation technologies, coupled with rising adoption of sterilization methods in emerging markets, are further accelerating the growth of the market.

Stringent regulatory requirements play a pivotal role in driving the biological indicators industry, as global health authorities mandate the validation of sterilization processes across industries such as medical devices, pharmaceuticals, and biotechnology. Biological indicators are the gold standard for confirming sterilization efficacy, making them a necessity for compliance. For instance, the U.S. Food and Drug Administration (FDA) requires medical device manufacturers to demonstrate sterilization validation under 21 CFR Part 820 (Quality System Regulation), while the European Medicines Agency (EMA) and the ISO 11138 standard outline specific criteria for biological indicator use in sterilization assurance. Similarly, compliance with Good Manufacturing Practices (GMP) in pharmaceuticals necessitates biological indicator-based validation for sterilized drug products and equipment. These strict regulatory frameworks ensure patient safety and product reliability, fueling consistent demand for biological indicators across critical healthcare and life sciences sectors.

The rising burden of hospital-acquired infections (HAIs) is a key factor driving the growth of the biological indicators industry, as healthcare facilities are increasingly focusing on strengthening infection control and sterilization practices. According to the WHO's Global Report on Infection Prevention and Control 2024, a large-scale systematic review of nearly 400 studies estimated the global prevalence of HAIs at around 14% in 2023. Furthermore, a European point prevalence survey conducted in 2022/2023 across 28 EU/EEA countries and three Western Balkan nations/territories reported an adjusted prevalence of 8% for patients with at least one HAI. This growing incidence of HAIs underscores the critical need for reliable sterilization validation, fueling the demand for biological indicators to ensure the effectiveness of sterilization processes over the forecast period.

The global rise in surgical procedures, ranging from elective operations to complex organ transplants, is significantly driving demand in the biological indicators industry. The growing procedural load in hospitals and surgical centers has led to a sharp increase in the daily use of reusable instruments that must undergo validated sterilization. This surge creates volume pressures and raises the bar for quality and compliance, pushing healthcare facilities to adopt stringent sterilization validation practices. According to the 2024 Procedural Statistics Release, approximately 1,585,878 cosmetic surgeries were performed in 2024, marking a 1% increase from 2023, while reconstructive procedures rose by 2% over the same period. The steady growth in surgical interventions highlights the critical need for biological indicators to ensure the effectiveness of sterilization processes and safeguard patient safety.

Technological advancements significantly shape the market by improving efficiency, accuracy, and compliance in sterilization validation. Innovations such as rapid-readout indicators have reduced the time required to confirm sterilization efficacy from several days to a few hours, accelerating instrument turnaround in busy healthcare facilities. For instance, in June 2025, Solventum introduced its Attest Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack, a ready-to-use solution that combines two previously FDA-cleared indicators into one test system. The pack integrates a biological indicator (BI) to confirm microbial inactivation and a chemical indicator (CI) to verify sterilizer performance, all within a transparent, single-use container for simplified and reliable sterilization validation.

"Innovations that make every load monitoring easier to adopt, more reliable, and faster across sterilization modalities empower healthcare facilities to consistently uphold the highest patient safety standards while supporting the increasing productivity demand of modern sterile processing departments," said Sharon Greene-Golden, past president of the Healthcare Sterile Processing Association (HSPA).

"In the high-stakes environment of sterile processing where patients' lives are at stake, both speed and accuracy are non-negotiable," said Doug Bartlett, senior vice president of the company's Infection Prevention & Surgical Solutions business. "Solventum innovations equip dedicated professionals with intuitive, cutting-edge resources that help them to safeguard patient health, reflecting our drive to continually support elevated standards of care in critical settings."

Global Biological Indicators Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global biological indicators market report based on product, method, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Self-Contained (Vials/Ampoules)
  • Strips
  • Cards / Rapid Readout BIs
  • Others
  • Method Outlook (Revenue, USD Million, 2021 - 2033)
  • Steam Sterilization
  • Ethylene Oxide Sterilization
  • Hydrogen Peroxide Sterilization
  • Irradiation Sterilization (Gamma, E-beam)
  • Dry Heat Sterilization
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics (CSSD / Infection Control Units)
  • Ambulatory Surgery Centers (ASCs) & Dental Clinics
  • Biopharma & Biotech Companies
  • Medical Device Manufacturers
  • Contract Sterilization Service Providers
  • Research & Academic Institutes
  • Other End Uses
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Third Party Perspective
    • 1.3.5. Primary research
    • 1.3.6. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
  • 1.7. Approach 1: Commodity flow approach
    • 1.7.1 Volume price analysis (Model 2)
  • 1.8. Approach 2: Volume price analysis
  • 1.9. List of Secondary Sources
  • 1.10. List of Primary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biological Indicators Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Healthcare-Associated Infections (HAIs)
      • 3.2.1.2. Stringent Regulatory Requirements and Standards
      • 3.2.1.3. Growth in Surgical Procedures and Healthcare Infrastructure
      • 3.2.1.4. Technological Innovation
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost of Advanced Indicators and Supporting Systems
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Integration with Digital/IoT & Automation
      • 3.2.3.2. Emerging Market Expansion
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Competition from Alternative & Less Expensive Technologies
  • 3.3. Biological Indicators Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining Power of Suppliers
      • 3.3.1.2. Bargaining Power of Buyers
      • 3.3.1.3. Threat of Substitutes
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape

Chapter 4. Biological Indicators Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biological Indicators Market: Product Movement Analysis & Market Share, 2024 & 2033
  • 4.3. Self-Contained
    • 4.3.1. Self-Contained Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Strips
    • 4.4.1. Strips Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Cards / Rapid Readout BIs
    • 4.5.1. Cards / Rapid Readout BIs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Biological Indicators Market: Method Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biological Indicators Market: Method Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Steam Sterilization
    • 5.3.1. Steam Sterilization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Ethylene Oxide Sterilization
    • 5.4.1. Ethylene Oxide Sterilization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Hydrogen Peroxide Sterilization
    • 5.5.1. Hydrogen Peroxide Sterilization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Irradiation Sterilization
    • 5.6.1. Irradiation Sterilization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Dry Heat Sterilization
    • 5.7.1. Dry Heat Sterilization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Biological Indicators Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Biological Indicators Market: End Use Movement Analysis & Market Share, 2024 & 2033
  • 6.3. Hospitals & Clinics
    • 6.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Ambulatory Surgery Centers (ASCs) & Dental Clinics
    • 6.4.1. Ambulatory Surgery Centers (ASCs) & Dental Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Biopharma & Biotech Companies
    • 6.5.1. Biopharma & Biotech Companies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Medical Device Manufacturers
    • 6.6.1. Medical Device Manufacturers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Contract Sterilization Service Providers
    • 6.7.1. Contract Sterilization Service Providers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Research & Academic Institutes
    • 6.8.1. Research & Academic Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Other End Uses
    • 6.9.1. Other End Uses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Biological Indicators Market: Regional Estimates & Trend Analysis by Product, Method, End Use

  • 7.1. Regional Outlook
  • 7.2. Biological Indicators Market: Regional Movement Analysis & Market Share, 2024 & 2033
  • 7.3. North America
    • 7.3.1. North America Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. U.S. Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Canada Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Mexico Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. UK Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Germany Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. France Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Scenario
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Italy Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Scenario
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Spain Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Scenario
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Denmark Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Scenario
      • 7.4.8.4. Reimbursement Scenario
      • 7.4.8.5. Sweden Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Scenario
      • 7.4.9.4. Reimbursement Scenario
      • 7.4.9.5. Norway Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Japan Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. China Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. India Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Reimbursement Scenario
      • 7.5.5.5. South Korea Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Reimbursement Scenario
      • 7.5.6.5. Australia Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Reimbursement Scenario
      • 7.5.7.5. Thailand Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Brazil Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Argentina Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. South Africa Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Saudi Arabia Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Scenario
      • 7.7.4.4. Reimbursement Scenario
      • 7.7.4.5. UAE Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Scenario
      • 7.7.5.4. Reimbursement Scenario
      • 7.7.5.5. Kuwait Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. STERIS plc.
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Solventum
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Getinge
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Mesa Laboratories, Inc.
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. 3M
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Terragene S.A.
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Propper Manufacturing Co., Inc.
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Tuttnauer
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Ecolab Inc.
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. H.W.Andersen Products Ltd.
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. MATACHANA GROUP
      • 8.2.11.1. Company Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Product Benchmarking
      • 8.2.11.4. Strategic Initiatives
    • 8.2.12. LISTER BIOMEDICAL CO.,LTD
      • 8.2.12.1. Company Overview
      • 8.2.12.2. Financial Performance
      • 8.2.12.3. Product Benchmarking
      • 8.2.12.4. Strategic Initiatives
    • 8.2.13. Liofilchem S.r.l.
      • 8.2.13.1. Company Overview
      • 8.2.13.2. Financial Performance
      • 8.2.13.3. Product Benchmarking
      • 8.2.13.4. Strategic Initiatives
    • 8.2.14. Steelco S.p.A.
      • 8.2.14.1. Company Overview
      • 8.2.14.2. Financial Performance
      • 8.2.14.3. Product Benchmarking
      • 8.2.14.4. Strategic Initiatives
    • 8.2.15. Zhejiang Tailin Bioengineering Co., Ltd.
      • 8.2.15.1. Company Overview
      • 8.2.15.2. Financial Performance
      • 8.2.15.3. Product Benchmarking
      • 8.2.15.4. Strategic Initiatives
    • 8.2.16. Cole-Parmer Instrument Company, LLC (Antylia Scientific)
      • 8.2.16.1. Company Overview
      • 8.2.16.2. Financial Performance
      • 8.2.16.3. Product Benchmarking
      • 8.2.16.4. Strategic Initiatives
    • 8.2.17. Anhui Tianrun Medical Packaging Materials Co., Ltd.
      • 8.2.17.1. Company Overview
      • 8.2.17.2. Financial Performance
      • 8.2.17.3. Product Benchmarking
      • 8.2.17.4. Strategic Initiatives
    • 8.2.18. Medline Industries, LP.
      • 8.2.18.1. Company Overview
      • 8.2.18.2. Financial Performance
      • 8.2.18.3. Product Benchmarking
      • 8.2.18.4. Strategic Initiatives
    • 8.2.19. True Indicating
      • 8.2.19.1. Company Overview
      • 8.2.19.2. Financial Performance
      • 8.2.19.3. Product Benchmarking
      • 8.2.19.4. Strategic Initiatives
  • 8.3. Company Market Share Analysis, 2024

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global biological indicators market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 4 Global biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 5 Global biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America biological indicators market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 9 North America biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 11 U.S. biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 12 U.S. biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 14 Canada biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 15 Canada biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 17 Mexico biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 18 Mexico biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe biological indicators market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 22 Europe biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 24 UK biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 25 UK biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Germany biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 27 Germany biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 28 Germany biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 30 France biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 31 France biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 33 Italy biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 34 Italy biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 36 Spain biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 37 Spain biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 39 Denmark biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 40 Denmark biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 42 Sweden biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 43 Sweden biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 45 Norway biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 46 Norway biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific biological indicators market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 51 China biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 52 China biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 53 China biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Japan biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 55 Japan biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 56 Japan biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 57 India biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 58 India biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 59 India biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 60 South Korea biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 61 South Korea biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 62 South Korea biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Australia biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 64 Australia biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 65 Australia biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Thailand biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 67 Thailand biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 68 Thailand biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Latin America biological indicators market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 71 Latin America biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 72 Latin America biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Brazil biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 74 Brazil biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 75 Brazil biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Argentina biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 77 Argentina biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 78 Argentina biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 79 MEA biological indicators market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 81 MEA biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 82 MEA biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 83 South Africa biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 84 South Africa biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 85 South Africa biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 89 UAE biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 90 UAE biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 91 UAE biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 94 Kuwait biological indicators market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Biological indicators market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Information procurement process
  • Fig. 5 Primary research pattern
  • Fig. 6 Biological indicators market snapshot, 2024 (USD Million)
  • Fig. 7 Segment snapshot, USD Million
  • Fig. 8 Competitive landscape snapshot
  • Fig. 9 Penetration & growth prospect mapping, by distribution channel
  • Fig. 10 Market driver analysis (Current & future impact)
  • Fig. 11 Market restraint analysis (Current & future impact)
  • Fig. 12 Self-contained market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Strips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Cards / rapid readout Bis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Steam sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Ethylene oxide sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Hydrogen peroxide sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Irradiation sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Dry heat sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Hospitals & clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Ambulatory surgery centers (ASCs) & dental clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Biopharma & biotech companies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Medical device manufacturers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Contract sterilization service providers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Research & academic institutes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Other end uses market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Biological indicators market: Regional key takeaways (USD Million)
  • Fig. 29 Biological indicators market: Regional outlook, 2024 & 2033 (USD Million)
  • Fig. 30 North America biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Canada biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Mexico biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Europe biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 UK biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Germany biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 France biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Spain biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Italy biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Sweden biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Norway biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Denmark biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Asia Pacific biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 China biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Japan biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 India biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 South Korea biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Australia biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Thailand biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Latin America biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Brazil biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Argentina biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Middle East and Africa biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 South Africa biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Saudi Arabia biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 UAE biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Kuwait biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 List of key emerging companies
  • Fig. 59 Company market share analysis, 2024
  • Fig. 60 Market differentiators
  • Fig. 61 Competitive dashboard analysis
  • Fig. 62 Regional network map